Virax Biolabs (VRAX) Minority Interest (2025 - 2026)
Virax Biolabs (VRAX) posted quarterly Minority Interest of -$242401.0 for Q1 2026, down 3.6% year-over-year from -$251465.8 in Q1 2025, and down 3.6% quarter-over-quarter from -$233967.0 in Q1 2025.
Virax Biolabs (VRAX) Minority Interest (2025 - 2026) Analysis & Trends
Virax Biolabs' Minority Interest history runs 2 years deep, the most recent figure standing at -$242401.0 for Q1 2026.
- In Q1 2026, Minority Interest fell 3.6% year-over-year to -$242401.0; the TTM figure through Mar 2026 stood at -$242401.0 (down 3.6% YoY), while the FY2026 annual figure was -$242401.0, down 3.6% from the prior year.
- Minority Interest for Q1 2026 stood at -$242401.0, down from -$233967.0 in the prior quarter.
- The five-year high for Minority Interest was -$233967.0 in Q1 2025, with the low at -$242401.0 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Virax Biolabs | 1.31 Mn | -5.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -242,401.00 |
| Mar 31, 2025 | -233,967.00 |